-
Je něco špatně v tomto záznamu ?
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
JP. Donnelly, SC. Chen, CA. Kauffman, WJ. Steinbach, JW. Baddley, PE. Verweij, CJ. Clancy, JR. Wingard, SR. Lockhart, AH. Groll, TC. Sorrell, M. Bassetti, H. Akan, BD. Alexander, D. Andes, E. Azoulay, R. Bialek, RW. Bradsher, S. Bretagne, T....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
MR/N006364/1
Medical Research Council - United Kingdom
MR/N006364/2
Medical Research Council - United Kingdom
PubMed
31802125
DOI
10.1093/cid/ciz1008
Knihovny.cz E-zdroje
- MeSH
- antifungální látky terapeutické užití MeSH
- hostitel s imunodeficiencí MeSH
- invazivní mykotické infekce * diagnóza farmakoterapie MeSH
- konsensus MeSH
- lidé MeSH
- mykózy * diagnóza farmakoterapie epidemiologie MeSH
- nádory * farmakoterapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have been of immense value to researchers who conduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies. However, their utility has not extended beyond patients with cancer or recipients of stem cell or solid organ transplants. With newer diagnostic techniques available, it was clear that an update of these definitions was essential. METHODS: To achieve this, 10 working groups looked closely at imaging, laboratory diagnosis, and special populations at risk of IFD. A final version of the manuscript was agreed upon after the groups' findings were presented at a scientific symposium and after a 3-month period for public comment. There were several rounds of discussion before a final version of the manuscript was approved. RESULTS: There is no change in the classifications of "proven," "probable," and "possible" IFD, although the definition of "probable" has been expanded and the scope of the category "possible" has been diminished. The category of proven IFD can apply to any patient, regardless of whether the patient is immunocompromised. The probable and possible categories are proposed for immunocompromised patients only, except for endemic mycoses. CONCLUSIONS: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
Alfred Health and Monash University Melbourne Australia
Ankara University Faculty of Medicine Cebeci Campus Hematology Clinical Research Unit Ankara Turkey
California Institute for Medical Research San Jose California USA
Center of Expertise in Mycology Radboudumc CWZ Nijmegen The Netherlands
Centre for Medical Microbiology University College London London UK
Critical Care Medicine Department NIH Clinical Center Bethesda Maryland USA
Department of Hematology and Oncology Lukas Hospital Buende Germany
Department of Hematology Radboudumc Nijmegen The Netherlands
Department of Hematology University Hospitals Leuven Leuven Belgium
Department of Internal Medicine Universidade Federal do Rio de Janeiro Rio de Janeiro Brazil
Department of Medicine Alpert Warren Medical School of Brown University Providence Rhode Island USA
Department of Medicine Division of Infectious Diseases Johns Hopkins University School
Department of Medicine University of Florida College of Medicine Gainesville Florida USA
Department of Microbiology Immunology and Transplantation K U Leuven Leuven Belgium
Department of Pediatrics Duke University Medical Center Durham North Carolina USA
Division of Infectious Disease University of Genova and San Martino University Hospital Genova Italy
Division of Infectious Diseases McGovern Medical School Houston Texas USA
Division of Infectious Diseases Medical College of Georgia Augusta University Augusta Georgia USA
Division of Infectious Diseases University of Arkansas for Medical Sciences Little Rock Arkansas USA
Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
Infectious Diseases Unit G Fracastoro Hospital San Bonifacio Verona Italy
Infectious Diseases Unit IRCCS Istituto Giannina Gaslini Genova Italy
Istituto di Ematologia Università Cattolica S Cuore Rome Italy
Médicine Intensive et Réanimation Hôpital Saint Louis APHP Université Paris Diderot Paris France
MiraVista Diagnostics Indianapolis Indiana USA
MRC Centre for Medical Mycology at the University of Aberdeen Aberdeen UK
Mycotic Diseases Branch Centers for Disease Control and Prevention Atlanta Georgia USA
Public Health Wales Mycology Reference Laboratory University Hospital of Wales Heath Park Cardiff UK
Spanish National Centre for Microbiology Instituto de Salud Carlos 3 Madrid Spain
University of Pittsburgh Pittsburg Pennsylvania USA
UT Health San Antonio and South Texas Veterans Health Care System San Antonio Texas USA
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020129
- 003
- CZ-PrNML
- 005
- 20210830101737.0
- 007
- ta
- 008
- 210728s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/cid/ciz1008 $2 doi
- 035 __
- $a (PubMed)31802125
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Donnelly, J Peter $u Department of Hematology, Radboudumc, Nijmegen, The Netherlands
- 245 10
- $a Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium / $c JP. Donnelly, SC. Chen, CA. Kauffman, WJ. Steinbach, JW. Baddley, PE. Verweij, CJ. Clancy, JR. Wingard, SR. Lockhart, AH. Groll, TC. Sorrell, M. Bassetti, H. Akan, BD. Alexander, D. Andes, E. Azoulay, R. Bialek, RW. Bradsher, S. Bretagne, T. Calandra, AM. Caliendo, E. Castagnola, M. Cruciani, M. Cuenca-Estrella, CF. Decker, SR. Desai, B. Fisher, T. Harrison, CP. Heussel, HE. Jensen, CC. Kibbler, DP. Kontoyiannis, BJ. Kullberg, K. Lagrou, F. Lamoth, T. Lehrnbecher, J. Loeffler, O. Lortholary, J. Maertens, O. Marchetti, KA. Marr, H. Masur, JF. Meis, CO. Morrisey, M. Nucci, L. Ostrosky-Zeichner, L. Pagano, TF. Patterson, JR. Perfect, Z. Racil, E. Roilides, M. Ruhnke, CS. Prokop, S. Shoham, MA. Slavin, DA. Stevens, GR. Thompson, JA. Vazquez, C. Viscoli, TJ. Walsh, A. Warris, LJ. Wheat, PL. White, TE. Zaoutis, PG. Pappas
- 520 9_
- $a BACKGROUND: Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have been of immense value to researchers who conduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies. However, their utility has not extended beyond patients with cancer or recipients of stem cell or solid organ transplants. With newer diagnostic techniques available, it was clear that an update of these definitions was essential. METHODS: To achieve this, 10 working groups looked closely at imaging, laboratory diagnosis, and special populations at risk of IFD. A final version of the manuscript was agreed upon after the groups' findings were presented at a scientific symposium and after a 3-month period for public comment. There were several rounds of discussion before a final version of the manuscript was approved. RESULTS: There is no change in the classifications of "proven," "probable," and "possible" IFD, although the definition of "probable" has been expanded and the scope of the category "possible" has been diminished. The category of proven IFD can apply to any patient, regardless of whether the patient is immunocompromised. The probable and possible categories are proposed for immunocompromised patients only, except for endemic mycoses. CONCLUSIONS: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
- 650 _2
- $a antifungální látky $x terapeutické užití $7 D000935
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hostitel s imunodeficiencí $7 D016867
- 650 12
- $a invazivní mykotické infekce $x diagnóza $x farmakoterapie $7 D000072742
- 650 12
- $a mykózy $x diagnóza $x farmakoterapie $x epidemiologie $7 D009181
- 650 12
- $a nádory $x farmakoterapie $7 D009369
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chen, Sharon C $u Centre for Infectious Diseases and Microbiology, Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, University of Sydney, Sydney, Australia
- 700 1_
- $a Kauffman, Carol A $u Division of Infectious Diseases, University of Michigan, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
- 700 1_
- $a Steinbach, William J $u Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA
- 700 1_
- $a Baddley, John W $u Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA
- 700 1_
- $a Verweij, Paul E $u Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands
- 700 1_
- $a Clancy, Cornelius J $u University of Pittsburgh, Pittsburg, Pennsylvania, USA
- 700 1_
- $a Wingard, John R $u Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
- 700 1_
- $a Lockhart, Shawn R $u Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- 700 1_
- $a Groll, Andreas H $u Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology and Oncology University Children's Hospital, Münster, Germany
- 700 1_
- $a Sorrell, Tania C $u University of Sydney, Marie Bashir Institute for Infectious Diseases & Biosecurity, University of Sydney School of Medicine Faculty of Medicine and Health, Westmead Institute for Centre for Infectious Diseases and Microbiology, Western Sydney Local Health District, Sydney, Australia
- 700 1_
- $a Bassetti, Matteo $u Infectious Disease Clinic, Department of Medicine University of Udine and Department of Health Sciences, DISSAL, University of Genoa, Genoa, Italy
- 700 1_
- $a Akan, Hamdi $u Ankara University, Faculty of Medicine, Cebeci Campus, Hematology Clinical Research Unit, Ankara, Turkey
- 700 1_
- $a Alexander, Barbara D $u Department of Medicine and Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA
- 700 1_
- $a Andes, David $u Division of Infectious Diseases, Departments of Medicine, Microbiology and Immunology School of Medicine and Public Health and School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA
- 700 1_
- $a Azoulay, Elie $u Médicine Intensive et Réanimation Hôpital Saint-Louis, APHP, Université Paris Diderot, Paris, France
- 700 1_
- $a Bialek, Ralf $u Molecular Diagnostics of Infectious Diseases, Microbiology, LADR Zentrallabor Dr. Kramer & Kollegen, Geesthacht, Germany
- 700 1_
- $a Bradsher, Robert W $u Division of Infectious Diseases, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
- 700 1_
- $a Bretagne, Stephane $u Institut Pasteur, Molecular Mycology Unit, CNRS UMR2000, Mycology Laboratory, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France
- 700 1_
- $a Calandra, Thierry $u Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Caliendo, Angela M $u Department of Medicine, Alpert Warren Medical School of Brown University, Providence, Rhode Island, USA
- 700 1_
- $a Castagnola, Elio $u Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
- 700 1_
- $a Cruciani, Mario $u Infectious Diseases Unit, G. Fracastoro Hospital, San Bonifacio, Verona, Italy
- 700 1_
- $a Cuenca-Estrella, Manuel $u Spanish National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a Decker, Catherine F $u Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
- 700 1_
- $a Desai, Sujal R $u National Heart & Lung Institute, Imperial College London, the Royal Brompton & Harefield NHS Foundation Trust, London, UK
- 700 1_
- $a Fisher, Brian $u Pediatric Infectious Diseases Division at the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- 700 1_
- $a Harrison, Thomas $u Centre for Global Health, Institute for Infection and Immunity, St Georges University of London, London, UK
- 700 1_
- $a Heussel, Claus Peter $u Diagnostic and Interventional Radiology, University Hospital Heidelberg, Translational Lung Research Center and Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik Heidelberg, Heidelberg, Germany
- 700 1_
- $a Jensen, Henrik E $u Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 700 1_
- $a Kibbler, Christopher C $u Centre for Medical Microbiology, University College London, London, UK
- 700 1_
- $a Kontoyiannis, Dimitrios P $u UT MD Anderson Cancer Center, Houston, Texas, USA
- 700 1_
- $a Kullberg, Bart-Jan $u Radboud Center for Infectious Diseases and Department of Medicine, Radboudumc, Nijmegen, The Netherlands
- 700 1_
- $a Lagrou, Katrien $u Department of Microbiology, Immunology and Transplantation and Department of Laboratory Medicine and National Reference Centre for Mycosis, University Hospitals Leuven, Leuven, Belgium
- 700 1_
- $a Lamoth, Frédéric $u Infectious Diseases Service, Department of Medicine and Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Lehrnbecher, Thomas $u Pediatric Hematology and Oncology, Hospital for Children and Adolescents, University of Frankfurt, Frankfurt, Germany
- 700 1_
- $a Loeffler, Jurgen $u Molecular Biology and Infection, Medical Hospital II, WÜ4i, University Hospital Würzburg, Würzburg, Germany
- 700 1_
- $a Lortholary, Olivier $u Paris University, Necker Pasteur Center for Infectious Diseases and Tropical Medicine, IHU Imagine & Institut Pasteur, Molecular Mycology Unit, CNRS UMR 2000, Paris, France
- 700 1_
- $a Maertens, Johan $u Department of Hematology, University Hospitals Leuven, Leuven, Belgium $u Department of Microbiology, Immunology and Transplantation, K.U. Leuven, Leuven, Belgium
- 700 1_
- $a Marchetti, Oscar $u Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Marr, Kieren A $u Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School
- 700 1_
- $a Masur, Henry $u Critical Care Medicine Department NIH-Clinical Center, Bethesda, Maryland, USA
- 700 1_
- $a Meis, Jacques F $u Department of Medical Microbiology and Infectious Diseases and Centre of Expertise in Mycology Radboudumc/Canisius Wilhelmina Hospital, Nijmegen, The Netherlands
- 700 1_
- $a Morrisey, C Orla $u Alfred Health and Monash University, Melbourne, Australia
- 700 1_
- $a Nucci, Marcio $u Department of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- 700 1_
- $a Ostrosky-Zeichner, Luis $u Division of Infectious Diseases, McGovern Medical School, Houston, Texas, USA
- 700 1_
- $a Pagano, Livio $u Istituto di Ematologia, Università Cattolica S. Cuore, Rome, Italy
- 700 1_
- $a Patterson, Thomas F $u UT Health San Antonio and South Texas Veterans Health Care System, San Antonio, Texas, USA
- 700 1_
- $a Perfect, John R $u Department of Medicine and Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA
- 700 1_
- $a Racil, Zdenek $u Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Roilides, Emmanuel $u Infectious Diseases Unit, 3rd Department of Pediatrics, Faculty of Medicine, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece
- 700 1_
- $a Ruhnke, Marcus $u Department of Hematology & Oncology, Lukas Hospital, Buende, Germany
- 700 1_
- $a Prokop, Cornelia Schaefer $u Meander Medical Center Amersfoort and Radiology, Radboud University Medical Center, Nijmegen, The Netherlands
- 700 1_
- $a Shoham, Shmuel $u Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School
- 700 1_
- $a Slavin, Monica A $u Department of Infectious Diseases, Peter MacCallum Cancer Center and the National Centre for Infections in Cancer, The University of Melbourne, Melbourne, Victoria, Australia
- 700 1_
- $a Stevens, David A $u Division of Infectious Diseases and Geographic Medicine, Stanford University Medical School, Stanford, California $u California Institute for Medical Research, San Jose, California, USA
- 700 1_
- $a Thompson, George R $u Department of Internal Medicine, Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California, USA
- 700 1_
- $a Vazquez, Jose A $u Division of Infectious Diseases, Medical College of Georgia/Augusta University, Augusta, Georgia, USA
- 700 1_
- $a Viscoli, Claudio $u Division of Infectious Disease, University of Genova and San Martino University Hospital, Genova, Italy
- 700 1_
- $a Walsh, Thomas J $u Weill Cornell Medicine of Cornell University, Departments of Medicine, Pediatrics, Microbiology & Immunology, New York, New York, USA
- 700 1_
- $a Warris, Adilia $u MRC Centre for Medical Mycology at the University of Aberdeen, Aberdeen, UK
- 700 1_
- $a Wheat, L Joseph $u MiraVista Diagnostics, Indianapolis, Indiana, USA
- 700 1_
- $a White, P Lewis $u Public Health Wales Mycology Reference Laboratory, University Hospital of Wales, Heath Park, Cardiff, UK
- 700 1_
- $a Zaoutis, Theoklis E $u Perelman School of Medicine at the University of Pennsylvania, Children's Hospital of Philadelphia and Roberts Center for Pediatric Research, Philadelphia, Pennsylvania, USA
- 700 1_
- $a Pappas, Peter G $u Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA
- 773 0_
- $w MED00001133 $t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America $x 1537-6591 $g Roč. 71, č. 6 (2020), s. 1367-1376
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31802125 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101737 $b ABA008
- 999 __
- $a ok $b bmc $g 1690838 $s 1140575
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 71 $c 6 $d 1367-1376 $e 20200912 $i 1537-6591 $m Clinical infectious diseases $n Clin Infect Dis $x MED00001133
- GRA __
- $a MR/N006364/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a MR/N006364/2 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20210728
